Description

A breast cancer monitor blood panel is used to track the progression of breast cancer by measuring levels of specific proteins, called tumor markers, in the blood, which can indicate whether the cancer is spreading or responding to treatment; this panel typically includes tests like CA 15-3 and CA 27-29, allowing doctors to monitor the effectiveness of therapy and detect potential recurrence of the cancer. 

This panel includes the following test:

Cancer Antigen (CA) 15-3 Blood Test

Cancer Antigen 27.29 Blood Test

Fasting not required.

Additional information about each test is listed below:

Cancer Antigen (CA) 15-3 Blood Test, which is used for monitoring the response to invasive breast cancer treatment and monitoring the recurrence of the disease. CA 15-3 is a tumor marker that is produced by certain cancer cells and released into the bloodstream. It triggers the body's immune system to defend against cancerous cells. While it is not used to screen or diagnose breast cancer specifically, it can help monitor certain types of cancers. Breast cancer is one of the cancers that can release CA 15-3, especially after treatment. 

Cancer Antigen 27.29 Blood Test monitors patients with metastatic breast cancer. CA 27.29 is a crucial protein that serves as a tumor marker to evaluate the advancement of cancer in an individual. It is a highly effective tool that can be employed to gauge the response to therapy or treatment.